You are here

  • Home
  • Archive
  • Volume 12, Issue 1
  • Review: varenicline, bupropion, and nicotine replacement therapies are effective for smoking cessation at 6 or 12 monthsCommentary

Article Text

Article menu
Download PDFPDF
Treatment
Review: varenicline, bupropion, and nicotine replacement therapies are effective for smoking cessation at 6 or 12 months

https://doi.org/10.1136/ebn.12.1.10

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    M J Eisenberg

    Dr M J Eisenberg, Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada; mark.eisenberg@mcgill.ca

    QUESTION

    How do various pharmacotherapies compare for smoking cessation?

    REVIEW SCOPE

    Studies selected compared any pharmacotherapy with placebo and reported biochemically validated measures of smoking abstinence. Trials that were unblinded or that evaluated reduced cigarette use, spontaneous cessation among smokers unwilling to quit, or smokers with chronic disease were excluded. Outcome was smoking cessation.

    REVIEW METHODS

    Medline, EMBASE/Excerpta Medica, Cochrane Library, and US Centers for Disease Control and Prevention’s Tobacco Information and Prevention database were searched for randomised controlled trials (RCTs). 69 RCTs (n = 32 908) …

    View Full Text

    Footnotes

    • Source of funding: Canadian Institutes of Health Research.